Cannabidiol for the treatment of cannabis use disorder: a phase 2a, double-blind, placebo-controlled, randomised, adaptive Bayesian trial

Tom P. Freeman, H. Valerie Curran, Abigail M. Freeman et al.|The Lancet Psychiatry|2020

Cited by 196